MARKET

BNGO

BNGO

Bionano Genomics Inc
NASDAQ
1.870
-0.100
-5.08%
After Hours: 1.910 +0.04 +2.14% 19:48 02/03 EST
OPEN
1.920
PREV CLOSE
1.970
HIGH
1.970
LOW
1.860
VOLUME
6.94M
TURNOVER
0
52 WEEK HIGH
4.350
52 WEEK LOW
1.160
MARKET CAP
555.25M
P/E (TTM)
-4.5777
1D
5D
1M
3M
1Y
5Y
Bionano Genomics Reaffirms Fiscal 2022 Revenue Guidance
Bionano Genomics Reaffirms Fiscal 2022 Revenue Guidance
MT Newswires · 2d ago
BTIG Reaffirms Their Buy Rating on BioNano Genomics (BNGO)
TipRanks · 4d ago
Bionano's Balance Sheet Challenges: History Repeating Itself
Seeking Alpha · 6d ago
Catalyst watch: Eyes on tech earnings, Chinese EV stocks, Peloton and Church & Dwight
Seeking Alpha · 01/27 19:15
Bionano Laboratories Expands Its Clinical Testing Menu With Launch Of Its First OGM-Based Laboratory Developed Test For Hematological Malignancies
Benzinga · 01/24 13:24
BRIEF-Bionano Announces Launch Of Next-Generation Versions Of Its Reagent Kits And Chip Consumable, Along With Updates To Its Instrument Control And Bionano Access Software
Reuters · 01/23 13:14
Bionano Announces Launch Of Next-Generation Versions Of Its Reagent Kits And Chip Consumable, Along With Updates To Its Instrument Control And Bionano Access Software For The Optical Genome Mapping Workflow
Benzinga · 01/23 13:05
BioNano Genomics (BNGO) Receives a Buy from Maxim Group
TipRanks · 01/21 18:25
More
About BNGO
Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sell the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Webull offers kinds of BioNano Genomics Inc stock information, including NASDAQ:BNGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNGO stock methods without spending real money on the virtual paper trading platform.